S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q1 2022

BVF Partners

Period: Q1 2022 Β· Filed: 2022-05-16
View on SEC EDGAR β†—
AUM
$2.50B
Total portfolio value
Positions
81
Reported securities
Top Holding
GHRS
6.8% $169.6M
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GHRSGH RESEARCH PLC$169.6M6.79%$18.29$27.01+47.7%
6.8%
KYMRKYMERA THERAPEUTICS INC$151.8M6.07%$42.32$113.51+168.2%
6.1%
RLAYRELAY THERAPEUTICS INC$135.6M5.42%$29.93$18.65-37.7%
5.4%
RCUSARCUS BIOSCIENCES INC$125.0M5.00%$31.56$30.33-3.9%
5.0%
MRUSMERUS N V$109.3M4.37%β€”β€”
4.4%
ARGXARGENX SE$99.7M3.99%$315.31$939.68+198.0%
4.0%
PTGXPROTAGONIST THERAPEUTICS INC$99.1M3.96%$23.68$131.62+455.8%
4.0%
XOMAXOMA CORP DEL$98.8M3.95%$27.98$43.00+53.7%
4.0%
RPTXREPARE THERAPEUTICS INC$83.4M3.34%β€”β€”
3.3%
ACRSACLARIS THERAPEUTICS INC$68.6M2.74%$17.24$5.56-67.8%
2.7%
CRNXCRINETICS PHARMACEUTICALS IN$65.9M2.64%$21.95$42.23+92.4%
2.6%
LKFTGALAPAGOS NV$64.9M2.60%$62.02$30.39-51.0%
2.6%
CGEMCULLINAN ONCOLOGY INC$56.2M2.25%$10.47$17.63+68.4%
2.3%
KURAKURA ONCOLOGY INC$51.5M2.06%$16.08$11.10-31.0%
2.1%
EQRXEQRX INC$49.7M1.99%β€”β€”
2.0%
XENEXENON PHARMACEUTICALS INC$48.9M1.95%$30.57$60.96+99.4%
1.9%
RVMDREVOLUTION MEDICINES INC$46.2M1.85%$25.51$189.24+641.8%
1.9%
ITOSITEOS THERAPEUTICS INC$45.1M1.80%β€”β€”
1.8%
RLMDRELMADA THERAPEUTICS INC$44.5M1.78%$26.99$6.28-76.7%
1.8%
CTICCTI BIOPHARMA CORP$41.7M1.67%β€”β€”
1.7%
SNDXSYNDAX PHARMACEUTICALS INC$41.6M1.66%$17.38$21.82+25.6%
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$40.3M1.61%$15.12$13.00-14.0%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$32.3M1.29%$18.49$19.40+4.9%
1.3%
OLMAOLEMA PHARMACEUTICALS INC$31.6M1.26%$4.26$12.64+196.7%
1.3%
CINCCINCOR PHARMA INC$30.4M1.22%β€”β€”
1.2%
LXRXLEXICON PHARMACEUTICALS INC$30.0M1.20%$2.09$2.32+11.0%
1.2%
ACIUAC IMMUNE SA$29.7M1.19%$4.00$2.51-37.3%
1.2%
STROSUTRO BIOPHARMA INC$28.3M1.13%$82.20$30.43-63.0%
1.1%
VSTMXXXXVERASTEM INC$28.2M1.13%β€”β€”
1.1%
PNTPOINT BIOPHARMA GLOBAL INC$26.8M1.07%β€”β€”
1.1%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (6)

TickerIssuerNotional
ITOSITEOS THERAPEUTICS INC$45.1M
CINCCINCOR PHARMA INC$30.4M
ANTXAN2 THERAPEUTICS INC$24.4M
IDYAIDEAYA BIOSCIENCES INC$17.9M
RDUSRADIUS HEALTH INC$3.3M
JNCEJOUNCE THERAPEUTICS INC$0.9M

Exited Positions (8)

TickerIssuerNotional
AMRNXXXXAMARIN CORP PLC$55.5M
KDNYCHINOOK THERAPEUTICS INC$29.4M
MIRMMIRUM PHARMACEUTICALS INC$7.0M
EUCRUEUCRATES BIOMEDICAL ACQU COR$5.0M
FLACUFRAZIER LIFESCIENCES ACQU CO$5.0M
FVAM5 01 ACQUISITION CORP$4.9M
RACBRESEARCH ALLIANCE CORP II$4.9M
JYACJIYA ACQUISITION CORP$2.9M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
VYGRVOYAGER THERAPEUTICS INC$9.0M+5256.3%
GBIOGENERATION BIO CO$19.2M+1382.7%
CNTACENTESSA PHARMACEUTICALS PLC$10.6M+286.2%
STROSUTRO BIOPHARMA INC$14.6M+272.7%-63.0%
ACRSACLARIS THERAPEUTICS INC$43.9M+134.5%-67.8%
ELDNELEDON PHARMACEUTICALS INC$3.1M+68.8%
PYXSPYXIS ONCOLOGY INC$-8.1M+59.8%
KURAKURA ONCOLOGY INC$22.6M+55.2%-31.0%

Trimmed (5)

TickerIssuerNotionalShares Ξ”Since Filing
XENEXENON PHARMACEUTICALS INC$-53.9M-51.4%+99.4%
LKFTGALAPAGOS NV$1.1M-9.5%-51.0%
VRDNVIRIDIAN THERAPEUTICS INC$-4.9M-7.2%+4.9%
WHWKAADI BIOSCIENCE INC$-6.8M-2.3%
LXRXLEXICON PHARMACEUTICALS INC$-26.6M+0.0%+11.0%
← Back to Hedge Funds